Your browser doesn't support javascript.
loading
Stratification of tumour cell radiation response and metabolic signatures visualization with Raman spectroscopy and explainable convolutional neural network.
Fuentes, Alejandra M; Milligan, Kirsty; Wiebe, Mitchell; Narayan, Apurva; Lum, Julian J; Brolo, Alexandre G; Andrews, Jeffrey L; Jirasek, Andrew.
Afiliación
  • Fuentes AM; Department of Physics, The University of British Columbia Okanagan Campus, Kelowna, Canada. andrew.jirasek@ubc.ca.
  • Milligan K; Department of Physics, The University of British Columbia Okanagan Campus, Kelowna, Canada. andrew.jirasek@ubc.ca.
  • Wiebe M; Department of Physics, The University of British Columbia Okanagan Campus, Kelowna, Canada. andrew.jirasek@ubc.ca.
  • Narayan A; Department of Computer Science, Western University, London, Canada.
  • Lum JJ; Department of Computer Science, The University of British Columbia Okanagan Campus, Kelowna, Canada.
  • Brolo AG; Department of Biochemistry and Microbiology, The University of Victoria, Victoria, Canada.
  • Andrews JL; Trev and Joyce Deeley Research Centre, BC Cancer, Victoria, Canada.
  • Jirasek A; Department of Chemistry, The University of Victoria, Victoria, Canada.
Analyst ; 149(5): 1645-1657, 2024 Feb 26.
Article en En | MEDLINE | ID: mdl-38312026
ABSTRACT
Reprogramming of cellular metabolism is a driving factor of tumour progression and radiation therapy resistance. Identifying biochemical signatures associated with tumour radioresistance may assist with the development of targeted treatment strategies to improve clinical outcomes. Raman spectroscopy (RS) can monitor post-irradiation biomolecular changes and signatures of radiation response in tumour cells in a label-free manner. Convolutional Neural Networks (CNN) perform feature extraction directly from data in an end-to-end learning manner, with high classification performance. Furthermore, recently developed CNN explainability techniques help visualize the critical discriminative features captured by the model. In this work, a CNN is developed to characterize tumour response to radiotherapy based on its degree of radioresistance. The model was trained to classify Raman spectra of three human tumour cell lines as radiosensitive (LNCaP) or radioresistant (MCF7, H460) over a range of treatment doses and data collection time points. Additionally, a method based on Gradient-Weighted Class Activation Mapping (Grad-CAM) was used to determine response-specific salient Raman peaks influencing the CNN predictions. The CNN effectively classified the cell spectra, with accuracy, sensitivity, specificity, and F1 score exceeding 99.8%. Grad-CAM heatmaps of H460 and MCF7 cell spectra (radioresistant) exhibited high contributions from Raman bands tentatively assigned to glycogen, amino acids, and nucleic acids. Conversely, heatmaps of LNCaP cells (radiosensitive) revealed activations at lipid and phospholipid bands. Finally, Grad-CAM variable importance scores were derived for glycogen, asparagine, and phosphatidylcholine, and we show that their trends over cell line, dose, and acquisition time agreed with previously established models. Thus, the CNN can accurately detect biomolecular differences in the Raman spectra of tumour cells of varying radiosensitivity without requiring manual feature extraction. Finally, Grad-CAM may help identify metabolic signatures associated with the observed categories, offering the potential for automated clinical tumour radiation response characterization.
Asunto(s)

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Espectrometría Raman / Redes Neurales de la Computación Tipo de estudio: Guideline / Prognostic_studies Límite: Humans Idioma: En Revista: Analyst Año: 2024 Tipo del documento: Article País de afiliación: Canadá Pais de publicación: Reino Unido

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Espectrometría Raman / Redes Neurales de la Computación Tipo de estudio: Guideline / Prognostic_studies Límite: Humans Idioma: En Revista: Analyst Año: 2024 Tipo del documento: Article País de afiliación: Canadá Pais de publicación: Reino Unido